CRC
VKTX icon

Curi RMB Capital’s Viking Therapeutics VKTX Stock Holding History

Curi RMB Capital’s Portfolio VKTX Stock Details VKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.59M Buy
66,310
+9,875
+17% +$319K 0.04% 316
2026
Q1 		$1.84M Buy
56,435
+1,606
+3% +$51.6K 0.03% 348
2025
Q4 		$1.93M Sell
54,829
-8
-0% -$283 0.03% 344
2025
Q3 		$1.44M Buy
54,837
+31
+0.1% +$925 0.03% 376
2025
Q2 		$1.45M Buy
54,806
+19,207
+54% +$506K 0.03% 369
2025
Q1 		$860K Buy
35,599
+29,565
+490% +$934K 0.02% 341
2024
Q4 		$243K Hold
6,034
– – 0.01% 489
2024
Q3 		$382K Buy
+6,034
New +$354K 0.01% 454

Other funds holding VKTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Curi RMB Capital's VKTX Position: Q2 2026 in Review

Curi RMB Capital increased its Viking Therapeutics (VKTX) stake by 17% in Q2 2026, buying an estimated $319K and bringing the position to 66,310 shares worth $2.59M. The position accounts for 0.04% of the portfolio, ranked #316.

Curi RMB Capital first reported a position in VKTX in Q3 2024 and has held it in 8 quarters since. 432 funds tracked by Wall St. Rank hold VKTX as of Q2 2026.

  • Curi RMB Capital held 66,310 shares of Viking Therapeutics worth $2.59M as of Q2 2026.
  • Curi RMB Capital bought 9,875 Viking Therapeutics shares in Q2 2026, an estimated $319K.
  • Viking Therapeutics made up 0.04% of Curi RMB Capital's portfolio in Q2 2026, its #316 holding.
  • Curi RMB Capital first reported a position in Viking Therapeutics in Q3 2024 and has held it in 8 quarters since.
  • 432 funds tracked by Wall St. Rank held Viking Therapeutics as of Q2 2026.

Based on Curi RMB Capital's 13F filing for Q2 2026, filed 14 Aug 2026.